How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Aseptic Packaging for Pharmaceutical Market
- By Packaging Material: Glass Vials, Plastic Bottles, Aluminum Cans, Blister Packs, Laminated Pouches
- By Sterilization Technique: Gamma Radiation, Ethylene Oxide (EtO) Sterilization, Autoclaving (Steam Sterilization), Electron Beam (E-Beam) Sterilization, Filtration Sterilization
- By Filling Technology: Isolator Technology, RABS (Restricted Access Barrier Systems), Blow-Fill-Seal (BFS) Technology, Aseptic Filling Lines, Pre-Filled Syringes
- By Drug Type: Injectables, Vaccines, Ophthalmic Solutions, Biologics, Nutraceuticals
- By End-Use Application: Hospitals, Pharmaceutical Manufacturing, Research Laboratories, Clinical Trials, Home Healthcare
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Glass Vials leads By Packaging Material at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 17 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 310 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.186 →
- 12 Company Profiles 17 players: SWOT & benchmarking p.194 →
Full report · locked preview
Everything inside the Aseptic Packaging for Pharmaceutical Market report
A complete, evidence-based study - 12 chapters and 130 sections covering market size, segmentation across 5 axes, regional analysis and 17 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
17 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Gerresheimer AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →SCHOTT AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →West Pharmaceutical Services Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Becton
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Dickinson and Company (BD)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Nipro Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →AptarGroup Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Amcor plc
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Berry Global Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Sartorius AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Fresenius Kabi
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Sidel Group
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Mold-Masters (a division of Milacron)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.227 →Tekni-Plex Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Ompi (Stevanato Group)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Catalent
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.250 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Glass Vials45.6
- Plastic Bottles12.4
- Aluminum Cans21.7
- Blister Packs9.3
- Laminated Pouches11.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Gerresheimer AG14.4
- SCHOTT AG21.6
- West Pharmaceutical Services Inc.8.7
- Becton9.5
- Dickinson and Company (BD)10.8
- Nipro Corporation7.0
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.3
- Europe23.3
- Asia Pacific20.2
- Latin America12.4
- Middle East and Africa11.8
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Gerresheimer AG | 84 | 90 | 75 | 93 | 86 | 92 | 87 |
| SCHOTT AG | 81 | 88 | 71 | 73 | 76 | 73 | 77 |
| West Pharmaceutical Services Inc. | 84 | 78 | 85 | 66 | 78 | 63 | 76 |
| Becton | 77 | 70 | 74 | 81 | 61 | 79 | 74 |
| Dickinson and Company (BD) | 72 | 59 | 65 | 55 | 68 | 58 | 63 |
| Nipro Corporation | 60 | 67 | 49 | 65 | 62 | 69 | 62 |
| AptarGroup Inc. | 57 | 63 | 62 | 51 | 63 | 41 | 56 |
| Amcor plc | 41 | 35 | 38 | 50 | 40 | 36 | 40 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Gerresheimer AG
- SCHOTT AG
- West Pharmaceutical Services Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Gerresheimer AG | ◐ | ✓ | ✓ | ◐ | ✓ | ✓ |
| SCHOTT AG | ◐ | ✓ | ◐ | ✓ | ◐ | ◐ |
| West Pharmaceutical Services Inc. | ◐ | ✓ | ✓ | ◐ | ✓ | ◐ |
| Becton | ◐ | ◐ | ✓ | ◐ | ◐ | ◐ |
| Dickinson and Company (BD) | ◐ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Nipro Corporation | − | ◐ | ◐ | − | − | ◐ |
| AptarGroup Inc. | ◐ | ◐ | − | − | ◐ | − |
| Amcor plc | − | − | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Challenger3
Strong scale, closing on the leaders.
Contender2
Focused players with pockets of strength.
Niche2
Specialists in a single segment or region.
Go-to-market strategy
Land Packaging Material in North America, then scale across Aseptic Packaging for Pharmaceutical Market — a $282M beachhead inside a $4.12B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Glass Vials
Best fit — highest urgency & budget in Packaging Material.
Plastic Bottles
Strong fit — clear ROI and a fast path to value.
Aluminum Cans
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Packaging Material in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Sterilization Technique & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Filling Technology
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Packaging Material leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Aseptic Packaging for Pharmaceutical Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
Aseptic Packaging for Pharmaceutical Market is a durable-growth opportunity — $5.22B by 2033, compounding at 6.2%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.2% CAGR
Demand compounds through 2033, outpacing GDP across Packaging Material.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Packaging Material moving from early to mainstream — durable secular demand.
Consolidation upside
17+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Sterilization Technique optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Aseptic Packaging for Pharmaceutical Market — a $5.69B market by 2033. Plan: grow share from 6.9% to 13.2%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.9% | 13.2% | On track |
| Revenue | $428M | $751M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 29.5% | 42.0% | On track |
| Customer retention | 89.6% | 93.4% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Packaging Material
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build Sterilization Technique capability
A defensible second engine — invest in Sterilization Technique to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Packaging Material share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Sterilization Technique
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $92M capacity & capability investment
- Greenlight bolt-on M&A in Sterilization Technique
- Authorise North America expansion plan
- Fund R&D program for Packaging Material leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskAhead
- Regulatory / policy changeOn track
- Execution & talentOn track
Sales deck · value proposition
Win the Aseptic Packaging for Pharmaceutical Market conversation — a $905M market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Packaging Material
Goal Grow share in Packaging Material
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Aseptic Packaging for Pharmaceutical Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
Aseptic Packaging for Pharmaceutical Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Dual Channel Atomic Fluorescence Spectrometer Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportDual Chamber Temporary Pacemaker Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportDual Chamber Syringe Filling Machine Market
Market size, share, segmentation and regional forecast.
$866M market · 2025 base year
View reportDual-chamber Pacemaker Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportGas Permeable Membrane Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportDual Chamber Injection Cartridge Market
Market size, share, segmentation and regional forecast.
$420M market · 2025 base year
View reportDual Chamber Drug Cartridge Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportDual Chamber Bag (DCB) Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportTamoxifen Citrate Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportArtificial Ceramic Teeth Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportLeadless Pacing Systems Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportDual Basin Automated Endoscope Reprocessor Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy